Cytophage Technologies (TSXV:CYTO) Ending Cash Position : C$5.57 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Ending Cash Position?

Cytophage Technologies's Ending Cash Position for the quarter that ended in Mar. 2024 was C$5.57 Mil.

Cytophage Technologies's quarterly Ending Cash Position increased from Sep. 2023 (C$0.00 Mil) to Dec. 2023 (C$0.01 Mil) and increased from Dec. 2023 (C$0.01 Mil) to Mar. 2024 (C$5.57 Mil).

Cytophage Technologies's annual Ending Cash Position declined from Dec. 2021 (C$4.84 Mil) to Dec. 2022 (C$0.07 Mil) and declined from Dec. 2022 (C$0.07 Mil) to Dec. 2023 (C$0.01 Mil).

Cytophage Technologies Ending Cash Position Historical Data

The historical data trend for Cytophage Technologies's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Ending Cash Position Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Ending Cash Position

4.84

0.07

0.01

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial			0.07	1.37	-	0.01	5.57

Cytophage Technologies Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Cytophage Technologies's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.069	+	-0.064
	=	0.01

Cytophage Technologies's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.032	+	5.536
	=	5.57

Cytophage Technologies Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.